Angiomyolipoma overview: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
Angiomyolipoma is a benign [[kidney|renal]] neoplasm previously considered to be a [[hamartoma]] or choristoma, but now known to be [[neoplastic]].<ref>Eble JN. Angiomyolipoma of the kidney. Semin Diagn Pathol 1988;15:21-40</ref> It is composed of variable amounts of [[fat]], [[Blood vessel|vascular]], and [[smooth muscle]] elements. The fat density of the tumor on [[CT]] has been regarded to be [[pathognomonic]]. The lesion is well demarcated and contains mature elements. It occurs in more than 50% of individuals with [[tuberous sclerosis]], often bilaterally. On [[gross pathology]], well circumscribed and uniform yellow mass is characteristic finding of [[angiomyolipoma]]. [[Angiomyolipoma]] is caused by a defect in the ''[[TSC1]]'' [[gene]]. [[Angiomyolipoma]] must be differentiated from [[retroperitoneal liposarcoma]], [[adrenal myelolipoma]], and [[renal cell carcinoma]]. If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few symptoms. Small angiomyolipomas are associated with the most favorable prognosis.Common complications of angiomyolipoma include [[infection]], [[hematuria]] and [[flank pain]]. Abdominal CT scan may be diagnostic for angiomyolipoma. On [[CT scan]], angiomyolipoma is characterized by smooth tumor margin with low intratumoral fat component and homogenous enhancement on both corticomedullary and excretory phase scans.<ref name="pmid14990834">{{cite journal| author=Kim JK, Park SY, Shon JH, Cho KS| title=Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. | journal=Radiology | year= 2004 | volume= 230 | issue= 3 | pages= 677-84 | pmid=14990834 | doi=10.1148/radiol.2303030003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14990834  }} </ref> Surgery is not the first-line treatment option for patients with angiomyolipoma. Transcatheter arterial embolization is usually reserved for patients with complicated disease.<ref name="pmid2864852">{{cite journal| author=Lewis JH, Weingold AB| title=The use of gastrointestinal drugs during pregnancy and lactation. | journal=Am J Gastroenterol | year= 1985 | volume= 80 | issue= 11 | pages= 912-23 | pmid=2864852 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2864852  }} </ref>
Angiomyolipoma is a benign [[kidney|renal]] neoplasm previously considered to be a [[hamartoma]] or choristoma, but now known to be [[neoplastic]].<ref>Eble JN. Angiomyolipoma of the kidney. Semin Diagn Pathol 1988;15:21-40</ref> It is composed of variable amounts of [[fat]], [[Blood vessel|vascular]], and [[smooth muscle]] elements. The fat density of the tumor on [[CT]] has been regarded to be [[pathognomonic]]. The lesion is well demarcated and contains mature elements. It occurs in more than 50% of individuals with [[tuberous sclerosis]], often bilaterally. On [[gross pathology]], well circumscribed and uniform yellow mass is characteristic finding of [[angiomyolipoma]]. [[Angiomyolipoma]] is caused by a defect in the ''[[TSC1]]'' [[gene]]. [[Angiomyolipoma]] must be differentiated from [[retroperitoneal liposarcoma]], [[adrenal myelolipoma]], and [[renal cell carcinoma]]. If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few symptoms. Small angiomyolipomas are associated with the most favorable prognosis.Common complications of angiomyolipoma include [[infection]], [[hematuria]] and [[hemorrhage]]. Abdominal CT scan may be diagnostic for angiomyolipoma. On [[CT scan]], angiomyolipoma is characterized by smooth tumor margin with low intratumoral fat component and homogenous enhancement on both corticomedullary and excretory phase scans.<ref name="pmid14990834">{{cite journal| author=Kim JK, Park SY, Shon JH, Cho KS| title=Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. | journal=Radiology | year= 2004 | volume= 230 | issue= 3 | pages= 677-84 | pmid=14990834 | doi=10.1148/radiol.2303030003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14990834  }} </ref> Surgery is not the first-line treatment option for patients with angiomyolipoma. Transcatheter arterial embolization is usually reserved for patients with complicated disease.<ref name="pmid2864852">{{cite journal| author=Lewis JH, Weingold AB| title=The use of gastrointestinal drugs during pregnancy and lactation. | journal=Am J Gastroenterol | year= 1985 | volume= 80 | issue= 11 | pages= 912-23 | pmid=2864852 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2864852  }} </ref>


==Classification==
==Classification==

Revision as of 16:00, 29 September 2015

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma overview

CDC on Angiomyolipoma overview

Angiomyolipoma overview in the news

Blogs on Angiomyolipoma overview

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3]

Overview

Angiomyolipoma is a benign renal neoplasm previously considered to be a hamartoma or choristoma, but now known to be neoplastic.[1] It is composed of variable amounts of fat, vascular, and smooth muscle elements. The fat density of the tumor on CT has been regarded to be pathognomonic. The lesion is well demarcated and contains mature elements. It occurs in more than 50% of individuals with tuberous sclerosis, often bilaterally. On gross pathology, well circumscribed and uniform yellow mass is characteristic finding of angiomyolipoma. Angiomyolipoma is caused by a defect in the TSC1 gene. Angiomyolipoma must be differentiated from retroperitoneal liposarcoma, adrenal myelolipoma, and renal cell carcinoma. If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few symptoms. Small angiomyolipomas are associated with the most favorable prognosis.Common complications of angiomyolipoma include infection, hematuria and hemorrhage. Abdominal CT scan may be diagnostic for angiomyolipoma. On CT scan, angiomyolipoma is characterized by smooth tumor margin with low intratumoral fat component and homogenous enhancement on both corticomedullary and excretory phase scans.[2] Surgery is not the first-line treatment option for patients with angiomyolipoma. Transcatheter arterial embolization is usually reserved for patients with complicated disease.[3]

Classification

Angiomyolipoma may be classified according to etiology into: tuberous sclerosis associated and isolated angiomyolipoma.

Pathophysiology

On gross pathology, well circumscribed and uniform yellow mass is characteristic finding of angiomyolipoma.

Causes

Angiomyolipoma is caused by a defect in the TSC1 gene. It can also be caused by a defect in another gene:TSC2.

Differentiating Angiomyolipoma from other Diseases

Angiomyolipoma must be differentiated from retroperitoneal liposarcoma, adrenal myelolipoma, and renal cell carcinoma.[4][5]

Epidemiology and Demographics

The incidence is approximately 30 per 100,000 individuals worldwide. Women are more commonly affected with angiomyolipoma than men.

Screening

Patients who have tuberous sclerosis should be screened for angiomyolipoma. Abdominal CT scan is recommended for screening of angiomyolipoma.[5]

Natural History, Complications and Prognosis

If left untreated, small angiomyolipomas and those without dilated blood vessels (aneurysms) cause few symptoms. Small angiomyolipomas are associated with the most favorable prognosis.Common complications of angiomyolipoma include infection, hematuria and flank pain.

History and Symptoms

Symptoms of angiomyolipoma include nausea, vomiting, and abdominal pain.

Physical Examination

Common physical examination findings of angiomyolipoma include fever, flank tenderness, and palpable mass.

Laboratory Findings

Laboratory findings consistent with the diagnosis of angiomyolipoma include presence of blood cells in urine and elevated white blood cell count.

CT

Abdominal CT scan may be diagnostic for angiomyolipoma. On CT scan, angiomyolipoma is characterized by smooth tumor margin with low intratumoral fat component and homogenous enhancement on both corticomedullary and excretory phase scans.[2]

MRI

Abdominal MRI may be diagnostic of angiomyolipoma. On MRI, angiomyolipoma is characterized by high signal intensity on non-fat saturated sequences, and loss of signal following fat saturation.

Ultrasound

On abdominal ultrasound, angiomyolipoma is characterized by hyperechoic lesions, located in the cortex and with posterior acoustic shadowing.

Other Imaging Studies

On digital subtraction angiography, angiolipoma is characterized by hypervascular lesions, microvascular aneurysms and absent AV shunting.

Medical Therapy

There is no medical therapy for angiomyolipoma; the mainstay of therapy is surgical resection or embolisation.

Surgery

Surgery is not the first-line treatment option for patients with angiomyolipoma. Transcatheter arterial embolization is usually reserved for patients with complicated disease.[3]

References

  1. Eble JN. Angiomyolipoma of the kidney. Semin Diagn Pathol 1988;15:21-40
  2. 2.0 2.1 Kim JK, Park SY, Shon JH, Cho KS (2004). "Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT". Radiology. 230 (3): 677–84. doi:10.1148/radiol.2303030003. PMID 14990834.
  3. 3.0 3.1 Lewis JH, Weingold AB (1985). "The use of gastrointestinal drugs during pregnancy and lactation". Am J Gastroenterol. 80 (11): 912–23. PMID 2864852.
  4. Patil, PA.; McKenney, JK.; Trpkov, K.; Hes, O.; Montironi, R.; Scarpelli, M.; Nesi, G.; Aron, M.; Sangoi, AR. (2014). "Renal Leiomyoma: A Contemporary Multi-institution Study of an Infrequent and Frequently Misclassified Neoplasm". Am J Surg Pathol. doi:10.1097/PAS.0000000000000354. PMID 25517956. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 Renal angiomyolipoma differential diagnosis. Dr Matt A. Morgan and Dr Behrang Amini et al. Radiopaedia 2015. http://radiopaedia.org/articles/renal-angiomyolipoma


Template:WikiDoc Sources